Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koert Ritmeijer

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2005
Treating HIV/AIDS and leishmaniasis coinfection in EthiopiaAranka Anema, Koert Ritmeijer
International Health|May 8, 2026
Neglected tropical diseases in conflict zones: devastating consequences of a lack of inclusionMargriet den Boer, Koert Ritmeijer
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2019
Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patientCharles Abongomera, Tullia Battaglioli, Cherinet Adera, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 25, 2008
ParomomycinRobert N Davidson, Margriet den Boer, Koert Ritmeijer
Plos One|September 23, 2016
A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort StudyCharles Abongomera, Francis Gatluak, Jozefine Buyze, et al.
Tropical Medicine & International Health : TM & IH|February 13, 2003
Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in SudanHans Veeken, Koert Ritmeijer, Jill Seaman, et al.
Plos Neglected Tropical Diseases|July 18, 2014
Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelinesJohan van Griensven, Koert Ritmeijer, Lutgarde Lynen, et al.
Emerging Infectious Diseases|February 2, 2010
Human African trypanosomiasis in areas without surveillanceFrancois Chappuis, Maria Angeles Lima, Laurence Flevaud, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin BFrançois Chappuis, Emilie Alirol, Dagemlidet T Worku, et al.
Plos Neglected Tropical Diseases|February 12, 2019
The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysisJoyce Pijpers, Margriet L den Boer, Dirk R Essink, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2005
Treating HIV/AIDS and leishmaniasis coinfection in EthiopiaAranka Anema, Koert Ritmeijer
International Health|May 8, 2026
Neglected tropical diseases in conflict zones: devastating consequences of a lack of inclusionMargriet den Boer, Koert Ritmeijer
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 22, 2019
Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patientCharles Abongomera, Tullia Battaglioli, Cherinet Adera, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 25, 2008
ParomomycinRobert N Davidson, Margriet den Boer, Koert Ritmeijer
Plos One|September 23, 2016
A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort StudyCharles Abongomera, Francis Gatluak, Jozefine Buyze, et al.
Tropical Medicine & International Health : TM & IH|February 13, 2003
Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in SudanHans Veeken, Koert Ritmeijer, Jill Seaman, et al.
Plos Neglected Tropical Diseases|July 18, 2014
Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelinesJohan van Griensven, Koert Ritmeijer, Lutgarde Lynen, et al.
Emerging Infectious Diseases|February 2, 2010
Human African trypanosomiasis in areas without surveillanceFrancois Chappuis, Maria Angeles Lima, Laurence Flevaud, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin BFrançois Chappuis, Emilie Alirol, Dagemlidet T Worku, et al.
Plos Neglected Tropical Diseases|February 12, 2019
The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysisJoyce Pijpers, Margriet L den Boer, Dirk R Essink, et al.
Pageof 10